Filter
1771
Filtered Results: 1771
Text search:
Diagnostics
and
Laboratory
Technology
Featured
Recommendations
185
New Publications
481
Language
Document type
No document type
909
Studies & Reports
317
Guidelines
282
Strategic & Response Plan
109
Manuals
108
Fact sheets
18
Training Material
11
Situation Updates
9
Brochures
2
Infographics
2
Online Courses
2
App
1
Resource Platforms
1
Countries / Regions
India
107
Global
70
Kenya
64
South Africa
47
Ethiopia
40
Nigeria
39
Liberia
38
Sierra Leone
35
Uganda
34
Tanzania
31
Western and Central Europe
30
Africa
29
Zambia
29
Rwanda
28
Latin America and the Carribbean
27
Nepal
24
Ghana
22
Namibia
20
Malawi
19
Bangladesh
17
Ukraine
16
South–East Asia Region
16
Philippines
15
Eastern Europe
14
Zimbabwe
13
Guinea
12
Asia
11
Botswana
11
Myanmar / Burma
11
Syria
10
Colombia
9
Lesotho
9
Cambodia
9
Congo, Democratic Republic of
9
West and Central Africa
9
East and Southern Africa
9
Senegal
8
Haiti
7
Argentina
7
Indonesia
7
Cameroon
6
Burkina Faso
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Eswatini/ Swaziland
6
Mozambique
5
USA
5
Brazil
5
Russia
5
Chile
4
Peru
4
Western Pacific Region
4
Bolivia
4
Tajikistan
3
Timor Leste/ East Timor
3
El Salvador
3
Afghanistan
3
North America
3
Vietnam
3
Sri Lanka
3
Iraq
3
Ecuador
3
North Macedonia
2
Thailand
2
Benin
2
China
2
Albania
2
Laos
2
Burundi
2
Bulgaria
2
Venezuela
2
Jordan
2
Germany
2
Paraguay
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Papua New Guinea
2
Georgia
2
Central African Republic
2
Pakistan
2
Gambia
1
Togo
1
Iran
1
Niger
1
Qatar
1
Dominican Republic
1
Hungary
1
Saudi Arabia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
France
1
United Kingdom
1
Moldova
1
Sudan
1
Yemen
1
Romania
1
Slovakia
1
Poland
1
Mali
1
Bhutan
1
South Sudan
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
714
Clinical Guidelines
183
Public Health
97
Key Resources
70
Pharmacy & Technologies
68
Women & Child Health
55
Capacity Building
16
Toolboxes
TB
211
COVID-19
139
AMR
121
HIV
116
Rapid Response
85
NTDs
79
Ebola & Marburg
48
Pharmacy
48
Caregiver
38
Planetary Health
31
Mental Health
30
Malaria
30
NCDs
28
Conflict
28
Zika
17
Health Financing Toolbox
16
Specific Hazards
14
Refugee
12
Global Health Education
11
Polio
9
Natural Hazards
8
Disability
8
Cholera
6
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
No publication year indicated
The specific objectives of the plan are to:
- Scale up evidence-based, cost effective interventions through effective strategies within a HSS approach and provide equitable coverage with quality.
- Reduce neonatal mortality by improved home-based newborn ...
The specific objectives of the plan are to:
- Scale up evidence-based, cost effective interventions through effective strategies within a HSS approach and provide equitable coverage with quality.
- Reduce neonatal mortality by improved home-based newborn ...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
National tuberculosis (TB) prevalence surveys provide a nationally representative measurement of the burden of TB disease in the population, at a given point in time. Repeat surveys allow assessment of trends and tracking of progress towards national and global targets for reductions in TB disease b...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a...
WHO recommends that a...
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and...
this toolkit presents a structured, rating-based methodology designed to provide a rapid, comprehensive assessment of the capacity of the human resource support system for a country’s supply chain. Data are gathered from a document review, focus group discussions, and in-country stakeholder interv...
The Compendium brings together for the first time key consensus-based policy recommendations and guidance to improve the delivery of proven interventions to women and children. The user-friendly format incorporates icons and tabs to present key health-related policies that support the delivery of es...
The coronavirus outbreak that began in 2019 (COVID-19) threatens to reverse years of hard-won gains in preventing and treating HIV. Fragile health systems are further stressed as health workers navigate an increased client load and demands at work while also being concerned for their own health and ...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
L'application de la technologie de santé numérique se développe rapidement en Afrique, dans
le but d'améliorer la prestation des services de santé et d'atteindre plus efficacement les
communautés éloignées et mal desservies. D'autre part, l'absence de lignes directrices et de
normes da...
Towards Universal Access to Prevention, Diagnosis and Treatment
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
The document provides detailed guidelines for managing cholera outbreaks, focusing on prevention, diagnosis, treatment, and control strategies. It emphasizes the importance of setting up Cholera Treatment Centers (CTCs), ensuring access to clean water, promoting hygiene, and utilizing oral rehydrati...
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control....
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
